The Pharmaceutical Post 8 (42/100)

The Pharmaceutical Post 8The Pharmaceutical Post 8 (42/100)The Pharmaceutical Post 8 - (1/100)The Pharmaceutical Post 8 - (2/100)The Pharmaceutical Post 8 - (3/100)The Pharmaceutical Post 8 - (4/100)The Pharmaceutical Post 8 - (5/100)The Pharmaceutical Post 8 - (6/100)The Pharmaceutical Post 8 - (7/100)The Pharmaceutical Post 8 - (8/100)The Pharmaceutical Post 8 - (9/100)The Pharmaceutical Post 8 - (10/100)The Pharmaceutical Post 8 - (11/100)The Pharmaceutical Post 8 - (12/100)The Pharmaceutical Post 8 - (13/100)The Pharmaceutical Post 8 - (14/100)The Pharmaceutical Post 8 - (15/100)The Pharmaceutical Post 8 - (16/100)The Pharmaceutical Post 8 - (17/100)The Pharmaceutical Post 8 - (18/100)The Pharmaceutical Post 8 - (19/100)The Pharmaceutical Post 8 - (20/100)The Pharmaceutical Post 8 - (21/100)The Pharmaceutical Post 8 - (22/100)The Pharmaceutical Post 8 - (23/100)The Pharmaceutical Post 8 - (24/100)The Pharmaceutical Post 8 - (25/100)The Pharmaceutical Post 8 - (26/100)The Pharmaceutical Post 8 - (27/100)The Pharmaceutical Post 8 - (28/100)The Pharmaceutical Post 8 - (29/100)The Pharmaceutical Post 8 - (30/100)The Pharmaceutical Post 8 - (31/100)The Pharmaceutical Post 8 - (32/100)The Pharmaceutical Post 8 - (33/100)The Pharmaceutical Post 8 - (34/100)The Pharmaceutical Post 8 - (35/100)The Pharmaceutical Post 8 - (36/100)The Pharmaceutical Post 8 - (37/100)The Pharmaceutical Post 8 - (38/100)The Pharmaceutical Post 8 - (39/100)The Pharmaceutical Post 8 - (40/100)The Pharmaceutical Post 8 - (41/100)The Pharmaceutical Post 8 - (42/100)The Pharmaceutical Post 8 - (43/100)The Pharmaceutical Post 8 - (44/100)The Pharmaceutical Post 8 - (45/100)The Pharmaceutical Post 8 - (46/100)The Pharmaceutical Post 8 - (47/100)The Pharmaceutical Post 8 - (48/100)The Pharmaceutical Post 8 - (49/100)The Pharmaceutical Post 8 - (50/100)The Pharmaceutical Post 8 - (51/100)The Pharmaceutical Post 8 - (52/100)The Pharmaceutical Post 8 - (53/100)The Pharmaceutical Post 8 - (54/100)The Pharmaceutical Post 8 - (55/100)The Pharmaceutical Post 8 - (56/100)The Pharmaceutical Post 8 - (57/100)The Pharmaceutical Post 8 - (58/100)The Pharmaceutical Post 8 - (59/100)The Pharmaceutical Post 8 - (60/100)The Pharmaceutical Post 8 - (61/100)The Pharmaceutical Post 8 - (62/100)The Pharmaceutical Post 8 - (63/100)The Pharmaceutical Post 8 - (64/100)The Pharmaceutical Post 8 - (65/100)The Pharmaceutical Post 8 - (66/100)The Pharmaceutical Post 8 - (67/100)The Pharmaceutical Post 8 - (68/100)The Pharmaceutical Post 8 - (69/100)The Pharmaceutical Post 8 - (70/100)The Pharmaceutical Post 8 - (71/100)The Pharmaceutical Post 8 - (72/100)The Pharmaceutical Post 8 - (73/100)The Pharmaceutical Post 8 - (74/100)The Pharmaceutical Post 8 - (75/100)The Pharmaceutical Post 8 - (76/100)The Pharmaceutical Post 8 - (77/100)The Pharmaceutical Post 8 - (78/100)The Pharmaceutical Post 8 - (79/100)The Pharmaceutical Post 8 - (80/100)The Pharmaceutical Post 8 - (81/100)The Pharmaceutical Post 8 - (82/100)The Pharmaceutical Post 8 - (83/100)The Pharmaceutical Post 8 - (84/100)The Pharmaceutical Post 8 - (85/100)The Pharmaceutical Post 8 - (86/100)The Pharmaceutical Post 8 - (87/100)The Pharmaceutical Post 8 - (88/100)The Pharmaceutical Post 8 - (89/100)The Pharmaceutical Post 8 - (90/100)The Pharmaceutical Post 8 - (91/100)The Pharmaceutical Post 8 - (92/100)The Pharmaceutical Post 8 - (93/100)The Pharmaceutical Post 8 - (94/100)The Pharmaceutical Post 8 - (95/100)The Pharmaceutical Post 8 - (96/100)The Pharmaceutical Post 8 - (97/100)The Pharmaceutical Post 8 - (98/100)The Pharmaceutical Post 8 - (99/100)The Pharmaceutical Post 8 - (100/100) Injectables / Interview Schreiner MediPharm L’étiquette, un élément de grande valeur pour sécuriser les injections Retour sur les dernières évolutions en matière d’étiquetage des produits injec- tables avec Stefan Wiedemann, Senior Director Strategic Marketing and Business Development chez Schreiner MediPharm, business unit de Schreiner Group GmbH & Co.KG. Quelles leçons tirez-vous d’optimiser les processus et de masquer de la crise sanitaire ? de manière fiable les produits expéri- mentaux. Il est essentiel aussi qu’elles soient adaptées aux applications cryo- Stefan Wiedemann : géniques à des températures extrême- La Covid-19 a contraint à accélérer ment basses. Lorsqu’un vaccin est prêt la mise sur le marché des candidats à être mis sur le marché, il y a la néces- vaccins. Au niveau de l’emballage et de sité d’adapter l’étiquette à l’application, l’étiquetage des produits injectables, il que ce soit pour les flacons unidoses est important d’avoir un soutien effi- ou multidoses, ou pour les seringues cace et fiable de la part de spécialistes, préremplies. Des fonctionnalités des essais cliniques au lancement sur le supplémentaires comme des parties marché jusqu’à la production en grand détachables, peuvent être une valeur Stefan Wiedemann, volume. Au niveau des essais cliniques, ajoutée. Et comme la contrefaçon est Senior Director Strategic Marketing and les solutions d’étiquetage permettent une menace permanente, encore plus Business Development chez Schreiner MediPharm Stefan Wiedemann, Senior Director Strategic Marketing and Business Development at Schreiner MediPharm Labels, a valuable feature to secure injections Overview of the latest developments in the labelling of injectable products with Stefan Wiedemann, Senior Director Strategic Marketing and Business Development at Schreiner MediPharm, Business Unit of Schreiner Group GmbH & Co.KG. speed up the launch on the market of market launch and large-scale produc- What are the lessons that vaccine candidates. Regarding the packa- tion. Regarding clinical trials, labelling you learnt during the health ging and labelling of injectable products, solutions help optimize the process and crisis? it is important to benefit from efficient reliably mask investigational products. It and reliable support from specialists, is also essential that they are suitable for Stefan Wiedemann: Covid-19 from the stage of clinical trials up to cryogenic applications at extremely low 42The Pharmaceutical Post 08 / Octobre - 2021